Weaker Buy Today ALNY ranks #1148 as BUY CANDIDATE. Stronger Buy
Today ALNY ranks #1148 as BUY CANDIDATE.

ALNY stock Alnylam Pharmaceuticals

ALNY stock
Alnylam Pharmaceuticals

February 15, 2019
Change 0.60%
Chart period: 2018-11-16 - 2019-02-15





Will ALNY stock price go up or down on Tue, 19 Feb 2019?

Alnylam Pharmaceuticals Forecast and Stock Analysis

Technical ALNY stock analysis for February 15, 2019.

Buy candidate since 2019-02-11 Gain 3.37%
Shorts n/a
Cash n/a
Loans n/a
Beta 2.60
ROA -43.71

Alnylam Pharmaceuticals gained 0.60% in the last trading day, rising from $83.03 to $83.53 The price has been going up and down for this period, and there has been a -1.24% loss for the last 2 weeks. Volume has increased in the last day along with the price, which is a positive technical sign, and, in total, 130 812 more shares were traded than the day before. In total, 528 748 shares bought and sold for approximately $44.17 million.

Close price at the end of the last trading day (Friday, 15th Feb 2019) of the ALNY stock was $83.53. This is 0.6% more than the trading day before Thursday, 14th Feb 2019.

During day the stock fluctuated 2.12% from a day low at $82.02 to a day high of $83.76.

30 day high of the ALNY stock price was $86.45 and low was $74.29.
90 day high was $90.70 and low was $60.27.
52 week high for the Alnylam Pharmaceuticals - $153.99 and low - $60.27.


Alnylam Pharmaceuticals lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 11.82% during the next 3 months and, with 90% probability hold a price between $76.69 and $104.29 at the end of this period.

Click here for today's Top 5 Trending Companies


Only positive signals in the chart today. Alnylam Pharmaceuticals holds buy signals from both short- and long-term moving averages. In addition, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down there will be some support from the lines at $82.01 and $80.74. A break down below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Thursday February 14, 2019, which indicates further gains until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

RSI14 is 64 and the stock is currently not being overbought or oversold

Access full RSI 14 and RSI 21 lists

Support & Resistance

Alnylam Pharmaceuticals finds support from accumulated volume at $80.45.

Support: $80.45 Price: $83.53 Resistance: $84.29


This stock is usually traded at good volume, and with minor daily changes the risk is considered to be low. During the last day, the stock moved $1.74 (2.12%) between high and low. For the last week, the stock has had a daily average volatility of 3.41%.

Our recommended stoploss: $78.67 (-5.82%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from pivot bottom found 1 days ago.)

Overall risk:

Very Low Low Medium High Very High

Evaluation: Buy Candidate

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for this stock to perform well in the short-term.

Weaker Buy Today ALNY ranks #1148 as BUY CANDIDATE. Stronger Buy
Today ALNY ranks #1148 as BUY CANDIDATE.